Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group
Katodritou, Eirini, Kastritis, Efstathios, Dalampira, Dimitra, Delimpasi, Sosana, Spanoudakis, Emmanouil, Labropoulou, Vasiliki, Ntanasis‐Stathopoulos, Ioannis, Gkioka, Annita‐Ioanna, Giannakoulas, Nikos, Kanellias, Nikolaos, Papadopoulou, Theodosia, Sevastoudi, Aggeliki, Michalis, Eyrydiki, Papathanasiou, Maria, Kotsopoulou, Maria, Sioni, Anastasia, Triantafyllou, Theodora, Daiou, Aikaterini, Papadatou, Mavra, Kyrtsonis, Marie‐Christine, Pouli, Anastasia, Kostopoulos, Ioannis, Verrou, Evgenia, Dimopoulos, Meletios‐Athanasios, Terpos, Evangelos
Published in American journal of hematology (01.05.2023)
Published in American journal of hematology (01.05.2023)
Get full text
Journal Article
Treatment with bortezomib‐based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group
Katodritou, Eirini, Terpos, Evangelos, Kelaidi, Charikleia, Kotsopoulou, Maria, Delimpasi, Sossana, Kyrtsonis, Marie‐Christine, Symeonidis, Argiris, Giannakoulas, Nikos, Stefanoudaki, Aikaterini, Christoulas, Dimitrios, Chatziaggelidou, Christina, Gastari, Vassiliki, Spyridis, Nikos, Verrou, Evgenia, Konstantinidou, Pavlina, Zervas, Kostas, Dimopoulos, Meletios A.
Published in American journal of hematology (01.02.2014)
Published in American journal of hematology (01.02.2014)
Get full text
Journal Article